US Patent Issued to The Regents of the University of California on April 7 for "Treating inflammation using LLP2A-bisphosphonate conjugates and mesenchymal stem cells" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,340, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.).

"Treating inflammation using LLP2A-bisphosphonate conjugates and mesenchymal stem cells" was invented by Nancy E. Lane (Hillsborough, Calif.), Ruiwu Liu (Sacramento, Calif.), Wei Yao (El Dorado Hills, Calif.) and Kit S. Lam (Davis, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of treating a subject having a primary inflammatory disease or disorder comprising administering to the subject a composition comprising a conjugate of an LLP2A peptidomimetic ligand a bisphosphonate drug, wherein the composition...